Sitryx Therapeutics
United KingdomEntry
2021
Hold
5yr
Status
Active
Who owns Sitryx Therapeutics?
Sitryx Therapeutics is a British Biotech company, currently owned by Sofinnova Partners since 2021 and SV Health Managers.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Most recent investor
Sofinnova PartnersSofinnova Capital X · 2021 · Life Sciences VC
2 ownership periods · full history below
Key facts
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2018 · present
SV Health ManagersActive
2018 · present(8yr) · SV Life Sciences Fund VI · 2015 · Life Sciences VC
Sofinnova PartnersActive
2021 · present(5yr) · Sofinnova Capital X · 2021 · Life Sciences VC
More from Sofinnova Capital X
Other portfolio companies in the same fund.
Germany
Denmark
France
Spain
USMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Sitryx Therapeutics?
Sitryx Therapeutics is currently owned by Sofinnova Partners and SV Health Managers, through Sofinnova Capital X, since 2021.
When did Sofinnova Partners and 1 other acquire Sitryx Therapeutics?
Sofinnova Partners and 1 other acquired Sitryx Therapeutics in 2021.
Who has owned Sitryx Therapeutics over time?
Sitryx Therapeutics has been through 2 private-equity ownership periods: SV Health Managers · via SV Life Sciences Fund VI · since 2018; Sofinnova Partners · via Sofinnova Capital X · since 2021.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue